Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02521363 |
|---|---|
| Brief Title: | Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer |
| First Submitted : | August 5, 2015 |
| First Submitted that Met QC Criteria : | August 10, 2015 |
| First Posted : | August 13, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 20, 2022 |
| Last Update Posted : | June 22, 2022 |